1.Application Research on Early Family Intervention in Prevention and Treatment of Cerebral Palsy
International Journal of Traditional Chinese Medicine 2008;30(6):477,479-
Objective To explore the effect of family early intervention on development of infants with prematurity and hypoxic ischemic encephalopathy(HIE).Methods 136 cases of premature infants,moderate and severe HIE infants were randomly divided into a treatment group and a control group.Every region of intelligence development was detected by Gesell Developmental Schedules at 16 weeks,28 weeks and 12 months respectively.Results Motor behavior,adaptive behavior,language behavior and personal social behavior increased obviously in the treatment group,while the incidence rate of cerebral palsy markedly decreased,showing a significant difference compared with the control group.Conclusion Early family intervention can efficiently improve the development of premature infants or infants with HIE,and prevent cerebral palsy from occurrence.
2.Clinical Observation on Treatment of 29 Cases of Infantile Cerebral Palsy with Acupuncture and Massage
International Journal of Traditional Chinese Medicine 2009;31(2):142-143
Objective To observe clinical effect of treating infantile cerebral palsy with acupuncture and massage. Methods 29 cases with cerebral palsy were randomly recurited into a control group and a treatment group. The treatment group was treated with acupuncture and massage, and the control group was treated with western medicine. The clinical effect of both groups was observed after the treatment. Results The total effective rate of the treatment group and the control group was 85.7% and 66.7% respectively, showing a significant difference (P<0.05) . Conclusion The treatment of infantile cerebral palsy with acupuncture and massage was better than treated with western medicine.
3.Water infusion versus air insufflation during the insertion phase of unsedated colonoscopy: a single-center single blind randomized controlled trial
He HUANG ; Hong SHI ; Suyu CHEN ; Zhaofei XIE
Chinese Journal of Digestive Endoscopy 2017;34(3):186-189
Objective To compare effects of warm water infusion and air insufflation on patient tolerance and satisfaction during the insertion phase of unsedated colonoscopy.Methods In a single-center,prospective,single blind randomized trial,patients were randomly assigned to three groups (water infusion group,air insufflation group,or hybrid method group) during the insertion phase of colonoscopy.Main outcome measurements included insertion time,cecal intubation rate,adenoma detection rate,the rate of position change,the rate of abdominal compression,intraoperative pain and distension VAS scores,postoperative pain and distension VAS scores.Results A total of 180 cases were enrolled,60 in each group.Patients in water infusion group and hybrid method group required less abdominal compression or position change,longer insertion time,reported lower intraoperative pain and distension VAS scores than air insufflation group during the insertion phase of colonoscopy.There were no significant differences in cecal intubation rates,adenoma detection rates,postoperative pain and distension or VAS scores among three groups.Conclusion Water infusion significantly decreases patient abdominal pain and distension during the insertion phase of colonoscopy without affecting cecal intubation rate and adenoma detection rate.
4.Clinical features and treatment outcome of extranodal nasal-type NK/T-cell lymphoma of the extra-upper aerodigestive tract
Yuting ZHAO ; Ying WANG ; Shunan QI ; Yong YANG ; Xia HE ; Yujing ZHANG ; Huiqiang HUANG ; Liling ZHANG ; Gang WU ; Baolin QU ; Liting QIAN ; Xiaorong HOU ; Fuquan ZHANG ; Xueying QIAO ; Hua WANG ; Gaofeng LI ; Yuan ZHU ; Jianzhong CAO ; Junxin WU ; Tao WU ; Suyu ZHU ; Mei SHI ; Liming XU ; Zhiyong YUAN ; Hang SU ; Yuqin SONG ; Jun ZHU ; Yexiong LI
Chinese Journal of Oncology 2021;43(7):787-794
Objective:To investigate the clinical features and prognosis of extranodal nasal-type NK/T-cell lymphoma of the extra-upper aerodigestive tract (extra-UADT NKTCL).Methods:The clinical data of 159 patients with extra-UADT NKTCL from the China Lymphoma Collaborative Group (CLCG) database between November 2001 and December 2015 were retrospectively analyzed. Kaplan-Meier survival analysis and Log-rank test were used to evaluate the prognosis. The Cox regression model is used for multi-factor analysis.Results:Extra-UADT NKTCL commonly occurs in skin and soft tissues (106/159, 66.7%) and gastrointestinal tract (31/159, 19.5%). The incidences of elevated lactate dehydrogenase (LDH) and Ann Arbor Ⅲ~Ⅳ stage were 47.8% (76/159) and 64.2% (102/159), respectively. The 3-year overall survival (OS) and progression-free survival (PFS) rates were 43.6% and 27.9%, respectively. The corresponding OS rates of primary skin/soft tissue site and gastrointestinal tract site were 41.0% and 59.4% ( P=0.281), while the PFS rates were 24.8% and 48.3%, respectively ( P=0.109). Combined modality treatment improved the 3-year OS of all the patients (58.4% vs 33.9%, P=0.001) and 3-year PFS (40.7% vs 20.7%, P=0.008) when compared with chemotherapy alone. LDH elevation, Ann Arbor synthesising and ≥2 junction external bits were intrusive as independent risk factors for total survival ( P<0.05), LDH elevation and ≥2 junction outer bits were intrusive as independent risk factors for progressionless survival( P<0.05). The distant extranodal dissemination was the primary failure patterns. Conclusions:Extra-UADT NKTCL appears to have distinct clinical characteristics and poor outcome. Compared with chemotherapy alone, combined modality treatment may improve the prognosis of patients with extra-UADT NKTCL.
5.Outcome of radiotherapy for low-risk early-stage patients with extranodal NK/T-cell lymphoma, nasal-type
Xiaodan WANG ; Xin LIU ; Tao WU ; Yong YANG ; Shunan QI ; Xia HE ; Liling ZHANG ; Gang WU ; Baolin QU ; Liting QIAN ; Xiaorong HOU ; Fuquan ZHANG ; Xueying QIAO ; Hua WANG ; Gaofeng LI ; Yuan ZHU ; Jianzhong CAO ; Junxin WU ; Suyu ZHU ; Mei SHI ; Hang SU ; Ximei ZHANG ; Huilai ZHANG ; Huiqiang HUANG ; Yujing ZHANG ; Yuqin SONG ; Jun ZHU ; Ying WANG ; Yexiong LI
Chinese Journal of Oncology 2021;43(10):1105-1113
Objective:To evaluate the prognosis and determine the failure patterns after radiotherapy for low-risk early-stage patients with extranodal NK/T-cell lymphoma, nasal-type (ENKTCL).Methods:A total of 557 patients from 2000—2015 with low-risk early-stage ENKTCL who received radiotherapy (RT) with or without chemotherapy (CT) from China Lymphoma Collaborative Group were retrospectively reviewed. Among them, 427 patients received combined modality therapy, whereas 130 patients received RT alone. Survivals were calculated by Kaplan-Meier method and compared with Log-rank test. Overall survival (OS) was compared with age and sex-matched general Chinese population using expected survival and standardized mortality ratio (SMR). Cox stepwise regression model was used for multivariate analysis.Results:The 5-year OS and progression-free survival (PFS) were 87.2% and 77.2%. The SMR was 3.59 ( P<0.001) at 1 year after treatment, whereas it was 1.50 at 4 years after treatment, without significant difference between ENKTCL group and country-matched general population ( P=0.146). Compared with RT alone, CMT did not result in significantly superior 5-year OS (87.0% vs 87.4%, P=0.961) or PFS (76.1% vs 80.7%, P=0.129). Local failure (11.5%, 64/557) and distant failure (10.8%, 60/557) were the main failure modes, while regional failure was rare (2.9%, 16/557). The 5-year locoregional control rate (LRC) was 87.2% for the whole group, with 89.5% for ≥50 Gy versus 73.7% for <50 Gy ( P<0.001). Radiotherapy dose was an independent factor affecting LRC( P<0.05). Conclusions:Radiotherapy achieves a favorable prognosis in patients with low-risk early-stage ENKTCL. The incidence of either locoregional or distant failure is low. Radiation dose still is an important prognostic factor for LRC.
6.Clinical features and treatment outcome of extranodal nasal-type NK/T-cell lymphoma of the extra-upper aerodigestive tract
Yuting ZHAO ; Ying WANG ; Shunan QI ; Yong YANG ; Xia HE ; Yujing ZHANG ; Huiqiang HUANG ; Liling ZHANG ; Gang WU ; Baolin QU ; Liting QIAN ; Xiaorong HOU ; Fuquan ZHANG ; Xueying QIAO ; Hua WANG ; Gaofeng LI ; Yuan ZHU ; Jianzhong CAO ; Junxin WU ; Tao WU ; Suyu ZHU ; Mei SHI ; Liming XU ; Zhiyong YUAN ; Hang SU ; Yuqin SONG ; Jun ZHU ; Yexiong LI
Chinese Journal of Oncology 2021;43(7):787-794
Objective:To investigate the clinical features and prognosis of extranodal nasal-type NK/T-cell lymphoma of the extra-upper aerodigestive tract (extra-UADT NKTCL).Methods:The clinical data of 159 patients with extra-UADT NKTCL from the China Lymphoma Collaborative Group (CLCG) database between November 2001 and December 2015 were retrospectively analyzed. Kaplan-Meier survival analysis and Log-rank test were used to evaluate the prognosis. The Cox regression model is used for multi-factor analysis.Results:Extra-UADT NKTCL commonly occurs in skin and soft tissues (106/159, 66.7%) and gastrointestinal tract (31/159, 19.5%). The incidences of elevated lactate dehydrogenase (LDH) and Ann Arbor Ⅲ~Ⅳ stage were 47.8% (76/159) and 64.2% (102/159), respectively. The 3-year overall survival (OS) and progression-free survival (PFS) rates were 43.6% and 27.9%, respectively. The corresponding OS rates of primary skin/soft tissue site and gastrointestinal tract site were 41.0% and 59.4% ( P=0.281), while the PFS rates were 24.8% and 48.3%, respectively ( P=0.109). Combined modality treatment improved the 3-year OS of all the patients (58.4% vs 33.9%, P=0.001) and 3-year PFS (40.7% vs 20.7%, P=0.008) when compared with chemotherapy alone. LDH elevation, Ann Arbor synthesising and ≥2 junction external bits were intrusive as independent risk factors for total survival ( P<0.05), LDH elevation and ≥2 junction outer bits were intrusive as independent risk factors for progressionless survival( P<0.05). The distant extranodal dissemination was the primary failure patterns. Conclusions:Extra-UADT NKTCL appears to have distinct clinical characteristics and poor outcome. Compared with chemotherapy alone, combined modality treatment may improve the prognosis of patients with extra-UADT NKTCL.
7.Outcome of radiotherapy for low-risk early-stage patients with extranodal NK/T-cell lymphoma, nasal-type
Xiaodan WANG ; Xin LIU ; Tao WU ; Yong YANG ; Shunan QI ; Xia HE ; Liling ZHANG ; Gang WU ; Baolin QU ; Liting QIAN ; Xiaorong HOU ; Fuquan ZHANG ; Xueying QIAO ; Hua WANG ; Gaofeng LI ; Yuan ZHU ; Jianzhong CAO ; Junxin WU ; Suyu ZHU ; Mei SHI ; Hang SU ; Ximei ZHANG ; Huilai ZHANG ; Huiqiang HUANG ; Yujing ZHANG ; Yuqin SONG ; Jun ZHU ; Ying WANG ; Yexiong LI
Chinese Journal of Oncology 2021;43(10):1105-1113
Objective:To evaluate the prognosis and determine the failure patterns after radiotherapy for low-risk early-stage patients with extranodal NK/T-cell lymphoma, nasal-type (ENKTCL).Methods:A total of 557 patients from 2000—2015 with low-risk early-stage ENKTCL who received radiotherapy (RT) with or without chemotherapy (CT) from China Lymphoma Collaborative Group were retrospectively reviewed. Among them, 427 patients received combined modality therapy, whereas 130 patients received RT alone. Survivals were calculated by Kaplan-Meier method and compared with Log-rank test. Overall survival (OS) was compared with age and sex-matched general Chinese population using expected survival and standardized mortality ratio (SMR). Cox stepwise regression model was used for multivariate analysis.Results:The 5-year OS and progression-free survival (PFS) were 87.2% and 77.2%. The SMR was 3.59 ( P<0.001) at 1 year after treatment, whereas it was 1.50 at 4 years after treatment, without significant difference between ENKTCL group and country-matched general population ( P=0.146). Compared with RT alone, CMT did not result in significantly superior 5-year OS (87.0% vs 87.4%, P=0.961) or PFS (76.1% vs 80.7%, P=0.129). Local failure (11.5%, 64/557) and distant failure (10.8%, 60/557) were the main failure modes, while regional failure was rare (2.9%, 16/557). The 5-year locoregional control rate (LRC) was 87.2% for the whole group, with 89.5% for ≥50 Gy versus 73.7% for <50 Gy ( P<0.001). Radiotherapy dose was an independent factor affecting LRC( P<0.05). Conclusions:Radiotherapy achieves a favorable prognosis in patients with low-risk early-stage ENKTCL. The incidence of either locoregional or distant failure is low. Radiation dose still is an important prognostic factor for LRC.